nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—Risedronate—osteoporosis	0.246	0.43	CbGbCtD
Mefenamic acid—CYP2C9—Estropipate—osteoporosis	0.0633	0.111	CbGbCtD
Mefenamic acid—CYP2C8—Raloxifene—osteoporosis	0.0606	0.106	CbGbCtD
Mefenamic acid—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0585	0.102	CbGbCtD
Mefenamic acid—CYP2C8—Cholecalciferol—osteoporosis	0.0468	0.0818	CbGbCtD
Mefenamic acid—CYP2C8—Estradiol—osteoporosis	0.0377	0.066	CbGbCtD
Mefenamic acid—CYP2C9—Cholecalciferol—osteoporosis	0.0326	0.0571	CbGbCtD
Mefenamic acid—CYP2C9—Estradiol—osteoporosis	0.0263	0.046	CbGbCtD
Mefenamic acid—Body temperature increased—Ibandronate—osteoporosis	0.000297	0.00109	CcSEcCtD
Mefenamic acid—Confusional state—Pamidronate—osteoporosis	0.000297	0.00109	CcSEcCtD
Mefenamic acid—Vertigo—Zoledronate—osteoporosis	0.000296	0.00109	CcSEcCtD
Mefenamic acid—Syncope—Zoledronate—osteoporosis	0.000295	0.00109	CcSEcCtD
Mefenamic acid—Leukopenia—Zoledronate—osteoporosis	0.000295	0.00108	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Pamidronate—osteoporosis	0.000294	0.00108	CcSEcCtD
Mefenamic acid—Oedema—Pamidronate—osteoporosis	0.000294	0.00108	CcSEcCtD
Mefenamic acid—Haemoglobin—Estradiol—osteoporosis	0.000293	0.00108	CcSEcCtD
Mefenamic acid—Infection—Pamidronate—osteoporosis	0.000292	0.00108	CcSEcCtD
Mefenamic acid—Urticaria—Calcitriol—osteoporosis	0.000292	0.00107	CcSEcCtD
Mefenamic acid—Hepatitis—Estradiol—osteoporosis	0.000292	0.00107	CcSEcCtD
Mefenamic acid—Haemorrhage—Estradiol—osteoporosis	0.000292	0.00107	CcSEcCtD
Mefenamic acid—Palpitations—Zoledronate—osteoporosis	0.000291	0.00107	CcSEcCtD
Mefenamic acid—Abdominal pain—Calcitriol—osteoporosis	0.000291	0.00107	CcSEcCtD
Mefenamic acid—Body temperature increased—Calcitriol—osteoporosis	0.000291	0.00107	CcSEcCtD
Mefenamic acid—Angioedema—Conjugated Estrogens—osteoporosis	0.00029	0.00107	CcSEcCtD
Mefenamic acid—Shock—Pamidronate—osteoporosis	0.00029	0.00107	CcSEcCtD
Mefenamic acid—Loss of consciousness—Zoledronate—osteoporosis	0.00029	0.00107	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Pamidronate—osteoporosis	0.000288	0.00106	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Estradiol—osteoporosis	0.000288	0.00106	CcSEcCtD
Mefenamic acid—Vomiting—Etidronic acid—osteoporosis	0.000288	0.00106	CcSEcCtD
Mefenamic acid—Tachycardia—Pamidronate—osteoporosis	0.000287	0.00106	CcSEcCtD
Mefenamic acid—Urethral disorder—Estradiol—osteoporosis	0.000286	0.00105	CcSEcCtD
Mefenamic acid—Rash—Etidronic acid—osteoporosis	0.000286	0.00105	CcSEcCtD
Mefenamic acid—Convulsion—Zoledronate—osteoporosis	0.000285	0.00105	CcSEcCtD
Mefenamic acid—Dermatitis—Etidronic acid—osteoporosis	0.000285	0.00105	CcSEcCtD
Mefenamic acid—Vertigo—Conjugated Estrogens—osteoporosis	0.000285	0.00105	CcSEcCtD
Mefenamic acid—Syncope—Conjugated Estrogens—osteoporosis	0.000285	0.00105	CcSEcCtD
Mefenamic acid—Hypertension—Zoledronate—osteoporosis	0.000284	0.00105	CcSEcCtD
Mefenamic acid—Headache—Etidronic acid—osteoporosis	0.000284	0.00104	CcSEcCtD
Mefenamic acid—Asthenia—Estropipate—osteoporosis	0.000281	0.00103	CcSEcCtD
Mefenamic acid—Anorexia—Pamidronate—osteoporosis	0.000281	0.00103	CcSEcCtD
Mefenamic acid—Palpitations—Conjugated Estrogens—osteoporosis	0.00028	0.00103	CcSEcCtD
Mefenamic acid—Insomnia—Risedronate—osteoporosis	0.00028	0.00103	CcSEcCtD
Mefenamic acid—Anxiety—Zoledronate—osteoporosis	0.00028	0.00103	CcSEcCtD
Mefenamic acid—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000279	0.00103	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000279	0.00102	CcSEcCtD
Mefenamic acid—Paraesthesia—Risedronate—osteoporosis	0.000278	0.00102	CcSEcCtD
Mefenamic acid—Pruritus—Estropipate—osteoporosis	0.000277	0.00102	CcSEcCtD
Mefenamic acid—Discomfort—Zoledronate—osteoporosis	0.000277	0.00102	CcSEcCtD
Mefenamic acid—Asthenia—Alendronate—osteoporosis	0.000277	0.00102	CcSEcCtD
Mefenamic acid—Dyspnoea—Risedronate—osteoporosis	0.000276	0.00102	CcSEcCtD
Mefenamic acid—Erythema multiforme—Estradiol—osteoporosis	0.000276	0.00101	CcSEcCtD
Mefenamic acid—Hypotension—Pamidronate—osteoporosis	0.000275	0.00101	CcSEcCtD
Mefenamic acid—Convulsion—Conjugated Estrogens—osteoporosis	0.000275	0.00101	CcSEcCtD
Mefenamic acid—Dry mouth—Zoledronate—osteoporosis	0.000274	0.00101	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000274	0.00101	CcSEcCtD
Mefenamic acid—Pruritus—Alendronate—osteoporosis	0.000273	0.001	CcSEcCtD
Mefenamic acid—Dyspepsia—Risedronate—osteoporosis	0.000273	0.001	CcSEcCtD
Mefenamic acid—Tinnitus—Estradiol—osteoporosis	0.000272	0.001	CcSEcCtD
Mefenamic acid—Constipation—Ethinyl Estradiol—osteoporosis	0.000272	0.000999	CcSEcCtD
Mefenamic acid—Confusional state—Zoledronate—osteoporosis	0.000271	0.000997	CcSEcCtD
Mefenamic acid—Asthenia—Ibandronate—osteoporosis	0.00027	0.000992	CcSEcCtD
Mefenamic acid—Anxiety—Conjugated Estrogens—osteoporosis	0.000269	0.00099	CcSEcCtD
Mefenamic acid—Nausea—Etidronic acid—osteoporosis	0.000269	0.00099	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Zoledronate—osteoporosis	0.000269	0.000989	CcSEcCtD
Mefenamic acid—Oedema—Zoledronate—osteoporosis	0.000269	0.000989	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000268	0.000987	CcSEcCtD
Mefenamic acid—Diarrhoea—Estropipate—osteoporosis	0.000268	0.000986	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Risedronate—osteoporosis	0.000267	0.000983	CcSEcCtD
Mefenamic acid—Infection—Zoledronate—osteoporosis	0.000267	0.000983	CcSEcCtD
Mefenamic acid—Insomnia—Pamidronate—osteoporosis	0.000266	0.000979	CcSEcCtD
Mefenamic acid—Pruritus—Ibandronate—osteoporosis	0.000266	0.000978	CcSEcCtD
Mefenamic acid—Constipation—Risedronate—osteoporosis	0.000265	0.000974	CcSEcCtD
Mefenamic acid—Shock—Zoledronate—osteoporosis	0.000265	0.000973	CcSEcCtD
Mefenamic acid—Paraesthesia—Pamidronate—osteoporosis	0.000264	0.000972	CcSEcCtD
Mefenamic acid—Diarrhoea—Alendronate—osteoporosis	0.000264	0.000971	CcSEcCtD
Mefenamic acid—Asthenia—Calcitriol—osteoporosis	0.000264	0.000971	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Zoledronate—osteoporosis	0.000263	0.000968	CcSEcCtD
Mefenamic acid—Dyspnoea—Pamidronate—osteoporosis	0.000262	0.000965	CcSEcCtD
Mefenamic acid—Tachycardia—Zoledronate—osteoporosis	0.000262	0.000965	CcSEcCtD
Mefenamic acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000262	0.000963	CcSEcCtD
Mefenamic acid—Somnolence—Pamidronate—osteoporosis	0.000262	0.000963	CcSEcCtD
Mefenamic acid—Skin disorder—Zoledronate—osteoporosis	0.000261	0.000961	CcSEcCtD
Mefenamic acid—Pruritus—Calcitriol—osteoporosis	0.00026	0.000957	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00026	0.000955	CcSEcCtD
Mefenamic acid—Diarrhoea—Raloxifene—osteoporosis	0.00026	0.000955	CcSEcCtD
Mefenamic acid—Dyspepsia—Pamidronate—osteoporosis	0.000259	0.000953	CcSEcCtD
Mefenamic acid—Dizziness—Estropipate—osteoporosis	0.000259	0.000953	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000259	0.000952	CcSEcCtD
Mefenamic acid—Oedema—Conjugated Estrogens—osteoporosis	0.000259	0.000952	CcSEcCtD
Mefenamic acid—Alopecia—Estradiol—osteoporosis	0.000258	0.000948	CcSEcCtD
Mefenamic acid—Infection—Conjugated Estrogens—osteoporosis	0.000257	0.000946	CcSEcCtD
Mefenamic acid—Diarrhoea—Ibandronate—osteoporosis	0.000257	0.000946	CcSEcCtD
Mefenamic acid—Anorexia—Zoledronate—osteoporosis	0.000256	0.000943	CcSEcCtD
Mefenamic acid—Decreased appetite—Pamidronate—osteoporosis	0.000256	0.000941	CcSEcCtD
Mefenamic acid—Mental disorder—Estradiol—osteoporosis	0.000256	0.00094	CcSEcCtD
Mefenamic acid—Dizziness—Alendronate—osteoporosis	0.000255	0.000939	CcSEcCtD
Mefenamic acid—Shock—Conjugated Estrogens—osteoporosis	0.000255	0.000937	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000254	0.000935	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Risedronate—osteoporosis	0.000253	0.000931	CcSEcCtD
Mefenamic acid—Tachycardia—Conjugated Estrogens—osteoporosis	0.000253	0.000929	CcSEcCtD
Mefenamic acid—Urticaria—Ethinyl Estradiol—osteoporosis	0.000252	0.000928	CcSEcCtD
Mefenamic acid—Constipation—Pamidronate—osteoporosis	0.000252	0.000926	CcSEcCtD
Mefenamic acid—Diarrhoea—Calcitriol—osteoporosis	0.000252	0.000926	CcSEcCtD
Mefenamic acid—Skin disorder—Conjugated Estrogens—osteoporosis	0.000252	0.000925	CcSEcCtD
Mefenamic acid—Hypotension—Zoledronate—osteoporosis	0.000251	0.000924	CcSEcCtD
Mefenamic acid—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000251	0.000923	CcSEcCtD
Mefenamic acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000251	0.000923	CcSEcCtD
Mefenamic acid—Dizziness—Raloxifene—osteoporosis	0.000251	0.000923	CcSEcCtD
Mefenamic acid—Flatulence—Estradiol—osteoporosis	0.00025	0.00092	CcSEcCtD
Mefenamic acid—Tension—Estradiol—osteoporosis	0.000249	0.000916	CcSEcCtD
Mefenamic acid—Vomiting—Estropipate—osteoporosis	0.000249	0.000916	CcSEcCtD
Mefenamic acid—Dizziness—Ibandronate—osteoporosis	0.000248	0.000914	CcSEcCtD
Mefenamic acid—Rash—Estropipate—osteoporosis	0.000247	0.000909	CcSEcCtD
Mefenamic acid—Dermatitis—Estropipate—osteoporosis	0.000247	0.000908	CcSEcCtD
Mefenamic acid—Anorexia—Conjugated Estrogens—osteoporosis	0.000247	0.000908	CcSEcCtD
Mefenamic acid—Nervousness—Estradiol—osteoporosis	0.000247	0.000907	CcSEcCtD
Mefenamic acid—Urticaria—Risedronate—osteoporosis	0.000246	0.000905	CcSEcCtD
Mefenamic acid—Headache—Estropipate—osteoporosis	0.000245	0.000903	CcSEcCtD
Mefenamic acid—Vomiting—Alendronate—osteoporosis	0.000245	0.000903	CcSEcCtD
Mefenamic acid—Abdominal pain—Risedronate—osteoporosis	0.000245	0.0009	CcSEcCtD
Mefenamic acid—Body temperature increased—Risedronate—osteoporosis	0.000245	0.0009	CcSEcCtD
Mefenamic acid—Rash—Alendronate—osteoporosis	0.000243	0.000895	CcSEcCtD
Mefenamic acid—Insomnia—Zoledronate—osteoporosis	0.000243	0.000895	CcSEcCtD
Mefenamic acid—Dermatitis—Alendronate—osteoporosis	0.000243	0.000894	CcSEcCtD
Mefenamic acid—Feeling abnormal—Pamidronate—osteoporosis	0.000243	0.000892	CcSEcCtD
Mefenamic acid—Hypotension—Conjugated Estrogens—osteoporosis	0.000242	0.00089	CcSEcCtD
Mefenamic acid—Headache—Alendronate—osteoporosis	0.000242	0.000889	CcSEcCtD
Mefenamic acid—Paraesthesia—Zoledronate—osteoporosis	0.000241	0.000888	CcSEcCtD
Mefenamic acid—Vomiting—Raloxifene—osteoporosis	0.000241	0.000888	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Pamidronate—osteoporosis	0.000241	0.000885	CcSEcCtD
Mefenamic acid—Dyspnoea—Zoledronate—osteoporosis	0.00024	0.000882	CcSEcCtD
Mefenamic acid—Rash—Raloxifene—osteoporosis	0.000239	0.00088	CcSEcCtD
Mefenamic acid—Dermatitis—Raloxifene—osteoporosis	0.000239	0.000879	CcSEcCtD
Mefenamic acid—Somnolence—Zoledronate—osteoporosis	0.000239	0.000879	CcSEcCtD
Mefenamic acid—Vomiting—Ibandronate—osteoporosis	0.000239	0.000879	CcSEcCtD
Mefenamic acid—Tremor—Estradiol—osteoporosis	0.000238	0.000875	CcSEcCtD
Mefenamic acid—Headache—Raloxifene—osteoporosis	0.000238	0.000875	CcSEcCtD
Mefenamic acid—Rash—Ibandronate—osteoporosis	0.000237	0.000871	CcSEcCtD
Mefenamic acid—Dermatitis—Ibandronate—osteoporosis	0.000237	0.000871	CcSEcCtD
Mefenamic acid—Dyspepsia—Zoledronate—osteoporosis	0.000237	0.000871	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Estradiol—osteoporosis	0.000236	0.000866	CcSEcCtD
Mefenamic acid—Headache—Ibandronate—osteoporosis	0.000235	0.000866	CcSEcCtD
Mefenamic acid—Insomnia—Conjugated Estrogens—osteoporosis	0.000234	0.000861	CcSEcCtD
Mefenamic acid—Vomiting—Calcitriol—osteoporosis	0.000234	0.00086	CcSEcCtD
Mefenamic acid—Decreased appetite—Zoledronate—osteoporosis	0.000234	0.00086	CcSEcCtD
Mefenamic acid—Nausea—Estropipate—osteoporosis	0.000233	0.000856	CcSEcCtD
Mefenamic acid—Abdominal pain—Pamidronate—osteoporosis	0.000233	0.000856	CcSEcCtD
Mefenamic acid—Body temperature increased—Pamidronate—osteoporosis	0.000233	0.000856	CcSEcCtD
Mefenamic acid—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000233	0.000855	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000232	0.000854	CcSEcCtD
Mefenamic acid—Angioedema—Estradiol—osteoporosis	0.000232	0.000853	CcSEcCtD
Mefenamic acid—Rash—Calcitriol—osteoporosis	0.000232	0.000853	CcSEcCtD
Mefenamic acid—Dermatitis—Calcitriol—osteoporosis	0.000232	0.000852	CcSEcCtD
Mefenamic acid—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000231	0.000849	CcSEcCtD
Mefenamic acid—Headache—Calcitriol—osteoporosis	0.00023	0.000848	CcSEcCtD
Mefenamic acid—Somnolence—Conjugated Estrogens—osteoporosis	0.00023	0.000847	CcSEcCtD
Mefenamic acid—Constipation—Zoledronate—osteoporosis	0.00023	0.000846	CcSEcCtD
Mefenamic acid—Nausea—Alendronate—osteoporosis	0.000229	0.000843	CcSEcCtD
Mefenamic acid—Malaise—Estradiol—osteoporosis	0.000229	0.000842	CcSEcCtD
Mefenamic acid—Vertigo—Estradiol—osteoporosis	0.000228	0.000839	CcSEcCtD
Mefenamic acid—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000228	0.000838	CcSEcCtD
Mefenamic acid—Asthenia—Ethinyl Estradiol—osteoporosis	0.000228	0.000838	CcSEcCtD
Mefenamic acid—Syncope—Estradiol—osteoporosis	0.000228	0.000837	CcSEcCtD
Mefenamic acid—Nausea—Raloxifene—osteoporosis	0.000225	0.000829	CcSEcCtD
Mefenamic acid—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000225	0.000828	CcSEcCtD
Mefenamic acid—Pruritus—Ethinyl Estradiol—osteoporosis	0.000225	0.000827	CcSEcCtD
Mefenamic acid—Palpitations—Estradiol—osteoporosis	0.000224	0.000825	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000224	0.000822	CcSEcCtD
Mefenamic acid—Nausea—Ibandronate—osteoporosis	0.000223	0.000821	CcSEcCtD
Mefenamic acid—Loss of consciousness—Estradiol—osteoporosis	0.000223	0.000821	CcSEcCtD
Mefenamic acid—Asthenia—Risedronate—osteoporosis	0.000222	0.000817	CcSEcCtD
Mefenamic acid—Feeling abnormal—Zoledronate—osteoporosis	0.000222	0.000815	CcSEcCtD
Mefenamic acid—Constipation—Conjugated Estrogens—osteoporosis	0.000221	0.000814	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Zoledronate—osteoporosis	0.00022	0.000809	CcSEcCtD
Mefenamic acid—Hypertension—Estradiol—osteoporosis	0.000219	0.000806	CcSEcCtD
Mefenamic acid—Pruritus—Risedronate—osteoporosis	0.000219	0.000806	CcSEcCtD
Mefenamic acid—Nausea—Calcitriol—osteoporosis	0.000219	0.000804	CcSEcCtD
Mefenamic acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000217	0.000799	CcSEcCtD
Mefenamic acid—Anxiety—Estradiol—osteoporosis	0.000215	0.000792	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000215	0.00079	CcSEcCtD
Mefenamic acid—Urticaria—Zoledronate—osteoporosis	0.000214	0.000786	CcSEcCtD
Mefenamic acid—Discomfort—Estradiol—osteoporosis	0.000214	0.000786	CcSEcCtD
Mefenamic acid—Body temperature increased—Zoledronate—osteoporosis	0.000213	0.000782	CcSEcCtD
Mefenamic acid—Abdominal pain—Zoledronate—osteoporosis	0.000213	0.000782	CcSEcCtD
Mefenamic acid—Diarrhoea—Risedronate—osteoporosis	0.000212	0.000779	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000212	0.000779	CcSEcCtD
Mefenamic acid—Dry mouth—Estradiol—osteoporosis	0.000211	0.000778	CcSEcCtD
Mefenamic acid—Asthenia—Pamidronate—osteoporosis	0.000211	0.000777	CcSEcCtD
Mefenamic acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.00021	0.000773	CcSEcCtD
Mefenamic acid—Confusional state—Estradiol—osteoporosis	0.000209	0.000769	CcSEcCtD
Mefenamic acid—Pruritus—Pamidronate—osteoporosis	0.000208	0.000766	CcSEcCtD
Mefenamic acid—Oedema—Estradiol—osteoporosis	0.000207	0.000762	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Estradiol—osteoporosis	0.000207	0.000762	CcSEcCtD
Mefenamic acid—Infection—Estradiol—osteoporosis	0.000206	0.000757	CcSEcCtD
Mefenamic acid—Urticaria—Conjugated Estrogens—osteoporosis	0.000206	0.000757	CcSEcCtD
Mefenamic acid—Dizziness—Risedronate—osteoporosis	0.000205	0.000753	CcSEcCtD
Mefenamic acid—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000205	0.000753	CcSEcCtD
Mefenamic acid—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000205	0.000753	CcSEcCtD
Mefenamic acid—Shock—Estradiol—osteoporosis	0.000204	0.00075	CcSEcCtD
Mefenamic acid—Tachycardia—Estradiol—osteoporosis	0.000202	0.000744	CcSEcCtD
Mefenamic acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.000202	0.000743	CcSEcCtD
Mefenamic acid—Diarrhoea—Pamidronate—osteoporosis	0.000201	0.000741	CcSEcCtD
Mefenamic acid—Skin disorder—Estradiol—osteoporosis	0.000201	0.00074	CcSEcCtD
Mefenamic acid—Rash—Ethinyl Estradiol—osteoporosis	0.0002	0.000737	CcSEcCtD
Mefenamic acid—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0002	0.000736	CcSEcCtD
Mefenamic acid—Headache—Ethinyl Estradiol—osteoporosis	0.000199	0.000732	CcSEcCtD
Mefenamic acid—Vomiting—Risedronate—osteoporosis	0.000197	0.000724	CcSEcCtD
Mefenamic acid—Rash—Risedronate—osteoporosis	0.000195	0.000718	CcSEcCtD
Mefenamic acid—Dermatitis—Risedronate—osteoporosis	0.000195	0.000717	CcSEcCtD
Mefenamic acid—Dizziness—Pamidronate—osteoporosis	0.000195	0.000716	CcSEcCtD
Mefenamic acid—Headache—Risedronate—osteoporosis	0.000194	0.000714	CcSEcCtD
Mefenamic acid—Asthenia—Zoledronate—osteoporosis	0.000193	0.00071	CcSEcCtD
Mefenamic acid—Pruritus—Zoledronate—osteoporosis	0.00019	0.0007	CcSEcCtD
Mefenamic acid—Nausea—Ethinyl Estradiol—osteoporosis	0.000189	0.000694	CcSEcCtD
Mefenamic acid—Insomnia—Estradiol—osteoporosis	0.000187	0.000689	CcSEcCtD
Mefenamic acid—Vomiting—Pamidronate—osteoporosis	0.000187	0.000688	CcSEcCtD
Mefenamic acid—Paraesthesia—Estradiol—osteoporosis	0.000186	0.000684	CcSEcCtD
Mefenamic acid—Asthenia—Conjugated Estrogens—osteoporosis	0.000186	0.000683	CcSEcCtD
Mefenamic acid—Rash—Pamidronate—osteoporosis	0.000186	0.000683	CcSEcCtD
Mefenamic acid—Dermatitis—Pamidronate—osteoporosis	0.000185	0.000682	CcSEcCtD
Mefenamic acid—Dyspnoea—Estradiol—osteoporosis	0.000185	0.00068	CcSEcCtD
Mefenamic acid—Headache—Pamidronate—osteoporosis	0.000184	0.000678	CcSEcCtD
Mefenamic acid—Somnolence—Estradiol—osteoporosis	0.000184	0.000678	CcSEcCtD
Mefenamic acid—Diarrhoea—Zoledronate—osteoporosis	0.000184	0.000677	CcSEcCtD
Mefenamic acid—Nausea—Risedronate—osteoporosis	0.000184	0.000677	CcSEcCtD
Mefenamic acid—Pruritus—Conjugated Estrogens—osteoporosis	0.000183	0.000674	CcSEcCtD
Mefenamic acid—Dyspepsia—Estradiol—osteoporosis	0.000182	0.000671	CcSEcCtD
Mefenamic acid—Decreased appetite—Estradiol—osteoporosis	0.00018	0.000663	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Estradiol—osteoporosis	0.000179	0.000658	CcSEcCtD
Mefenamic acid—Dizziness—Zoledronate—osteoporosis	0.000178	0.000654	CcSEcCtD
Mefenamic acid—Constipation—Estradiol—osteoporosis	0.000177	0.000652	CcSEcCtD
Mefenamic acid—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000177	0.000652	CcSEcCtD
Mefenamic acid—Nausea—Pamidronate—osteoporosis	0.000175	0.000643	CcSEcCtD
Mefenamic acid—Dizziness—Conjugated Estrogens—osteoporosis	0.000171	0.00063	CcSEcCtD
Mefenamic acid—Vomiting—Zoledronate—osteoporosis	0.000171	0.000629	CcSEcCtD
Mefenamic acid—Feeling abnormal—Estradiol—osteoporosis	0.000171	0.000628	CcSEcCtD
Mefenamic acid—Rash—Zoledronate—osteoporosis	0.00017	0.000624	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Estradiol—osteoporosis	0.000169	0.000623	CcSEcCtD
Mefenamic acid—Dermatitis—Zoledronate—osteoporosis	0.000169	0.000623	CcSEcCtD
Mefenamic acid—Headache—Zoledronate—osteoporosis	0.000168	0.00062	CcSEcCtD
Mefenamic acid—Vomiting—Conjugated Estrogens—osteoporosis	0.000165	0.000605	CcSEcCtD
Mefenamic acid—Urticaria—Estradiol—osteoporosis	0.000165	0.000605	CcSEcCtD
Mefenamic acid—Abdominal pain—Estradiol—osteoporosis	0.000164	0.000603	CcSEcCtD
Mefenamic acid—Body temperature increased—Estradiol—osteoporosis	0.000164	0.000603	CcSEcCtD
Mefenamic acid—Rash—Conjugated Estrogens—osteoporosis	0.000163	0.0006	CcSEcCtD
Mefenamic acid—Dermatitis—Conjugated Estrogens—osteoporosis	0.000163	0.0006	CcSEcCtD
Mefenamic acid—Headache—Conjugated Estrogens—osteoporosis	0.000162	0.000597	CcSEcCtD
Mefenamic acid—Nausea—Zoledronate—osteoporosis	0.00016	0.000587	CcSEcCtD
Mefenamic acid—Nausea—Conjugated Estrogens—osteoporosis	0.000154	0.000566	CcSEcCtD
Mefenamic acid—Asthenia—Estradiol—osteoporosis	0.000149	0.000547	CcSEcCtD
Mefenamic acid—Pruritus—Estradiol—osteoporosis	0.000147	0.000539	CcSEcCtD
Mefenamic acid—Diarrhoea—Estradiol—osteoporosis	0.000142	0.000521	CcSEcCtD
Mefenamic acid—Dizziness—Estradiol—osteoporosis	0.000137	0.000504	CcSEcCtD
Mefenamic acid—Vomiting—Estradiol—osteoporosis	0.000132	0.000485	CcSEcCtD
Mefenamic acid—Rash—Estradiol—osteoporosis	0.000131	0.000481	CcSEcCtD
Mefenamic acid—Dermatitis—Estradiol—osteoporosis	0.000131	0.00048	CcSEcCtD
Mefenamic acid—Headache—Estradiol—osteoporosis	0.00013	0.000477	CcSEcCtD
Mefenamic acid—Nausea—Estradiol—osteoporosis	0.000123	0.000453	CcSEcCtD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.52e-05	0.000609	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	9.5e-05	0.000608	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PSMA5—osteoporosis	9.45e-05	0.000605	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PSMA2—osteoporosis	9.45e-05	0.000605	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—POMC—osteoporosis	9.44e-05	0.000604	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—MTHFR—osteoporosis	9.39e-05	0.000601	CbGpPWpGaD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.34e-05	0.000598	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.27e-05	0.000593	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ENO1—osteoporosis	9.21e-05	0.00059	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CYP19A1—osteoporosis	9.17e-05	0.000587	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.11e-05	0.000583	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PSMA2—osteoporosis	9.08e-05	0.000581	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PSMA5—osteoporosis	9.08e-05	0.000581	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—ADCY5—osteoporosis	8.94e-05	0.000572	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PKM—osteoporosis	8.9e-05	0.000569	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—FDPS—osteoporosis	8.9e-05	0.000569	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CALCA—osteoporosis	8.81e-05	0.000563	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	8.69e-05	0.000556	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CALCA—osteoporosis	8.46e-05	0.000541	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PGLS—osteoporosis	8.44e-05	0.00054	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GPD2—osteoporosis	8.44e-05	0.00054	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SOST—osteoporosis	8.44e-05	0.00054	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PKM—osteoporosis	8.44e-05	0.00054	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—P4HB—osteoporosis	8.35e-05	0.000534	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.32e-05	0.000533	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	8.25e-05	0.000528	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MTHFR—osteoporosis	8.23e-05	0.000526	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	8.14e-05	0.000521	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTH—osteoporosis	8.12e-05	0.00052	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PGLS—osteoporosis	8e-05	0.000512	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ANTXR2—osteoporosis	8e-05	0.000512	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KL—osteoporosis	8e-05	0.000512	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RAP1A—osteoporosis	7.98e-05	0.000511	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CNR2—osteoporosis	7.91e-05	0.000506	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IRS2—osteoporosis	7.83e-05	0.000501	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NFATC1—osteoporosis	7.79e-05	0.000498	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.75e-05	0.000496	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.74e-05	0.000496	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—DKK1—osteoporosis	7.73e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ENO1—osteoporosis	7.72e-05	0.000494	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PNP—osteoporosis	7.72e-05	0.000494	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ATIC—osteoporosis	7.72e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KL—osteoporosis	7.68e-05	0.000492	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	7.68e-05	0.000492	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	7.66e-05	0.00049	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PSMA2—osteoporosis	7.6e-05	0.000487	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PSMA5—osteoporosis	7.6e-05	0.000487	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.55e-05	0.000483	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	7.51e-05	0.000481	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—POMC—osteoporosis	7.51e-05	0.00048	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ADCY5—osteoporosis	7.49e-05	0.000479	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GPX1—osteoporosis	7.46e-05	0.000478	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—WNT1—osteoporosis	7.44e-05	0.000476	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.41e-05	0.000474	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FGA—osteoporosis	7.24e-05	0.000463	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—FDPS—osteoporosis	7.06e-05	0.000452	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PKM—osteoporosis	7.06e-05	0.000452	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	7.01e-05	0.000448	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	6.89e-05	0.000441	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—MTHFR—osteoporosis	6.89e-05	0.000441	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IRS1—osteoporosis	6.83e-05	0.000437	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GSN—osteoporosis	6.8e-05	0.000435	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—BMP2—osteoporosis	6.73e-05	0.000431	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTHLH—osteoporosis	6.73e-05	0.000431	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PGLS—osteoporosis	6.7e-05	0.000429	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GPD2—osteoporosis	6.7e-05	0.000429	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	6.63e-05	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FGB—osteoporosis	6.59e-05	0.000421	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—OXCT1—osteoporosis	6.56e-05	0.00042	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CA2—osteoporosis	6.56e-05	0.00042	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6R—osteoporosis	6.42e-05	0.000411	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MGLL—osteoporosis	6.39e-05	0.000409	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PSMA5—osteoporosis	6.36e-05	0.000407	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PSMA2—osteoporosis	6.36e-05	0.000407	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.3e-05	0.000403	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ADCY5—osteoporosis	6.26e-05	0.000401	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP19A1—osteoporosis	6.17e-05	0.000395	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PNP—osteoporosis	6.13e-05	0.000392	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ATIC—osteoporosis	6.13e-05	0.000392	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—POMC—osteoporosis	6.09e-05	0.00039	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SPP1—osteoporosis	6.06e-05	0.000388	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.03e-05	0.000386	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.03e-05	0.000386	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ADCY5—osteoporosis	6.02e-05	0.000385	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CALCA—osteoporosis	5.92e-05	0.000379	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LRP5—osteoporosis	5.92e-05	0.000379	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MYC—osteoporosis	5.85e-05	0.000375	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	5.84e-05	0.000374	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—FDPS—osteoporosis	5.75e-05	0.000368	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PKM—osteoporosis	5.75e-05	0.000368	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LRP6—osteoporosis	5.66e-05	0.000362	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	5.56e-05	0.000356	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MTHFR—osteoporosis	5.54e-05	0.000354	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—POMC—osteoporosis	5.51e-05	0.000353	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IRS2—osteoporosis	5.48e-05	0.000351	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TNF—osteoporosis	5.45e-05	0.000349	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPD2—osteoporosis	5.45e-05	0.000349	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PGLS—osteoporosis	5.45e-05	0.000349	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—IDH2—osteoporosis	5.44e-05	0.000348	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPL24—osteoporosis	5.44e-05	0.000348	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LTF—osteoporosis	5.44e-05	0.000348	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KL—osteoporosis	5.38e-05	0.000344	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—LEP—osteoporosis	5.36e-05	0.000343	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IRS2—osteoporosis	5.27e-05	0.000337	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CA2—osteoporosis	5.21e-05	0.000333	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—OXCT1—osteoporosis	5.21e-05	0.000333	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.13e-05	0.000328	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ESR1—osteoporosis	5.12e-05	0.000328	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP27A1—osteoporosis	5.11e-05	0.000327	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MGLL—osteoporosis	5.08e-05	0.000325	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ADCY5—osteoporosis	5.04e-05	0.000322	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GPX1—osteoporosis	5.02e-05	0.000321	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ATIC—osteoporosis	4.98e-05	0.000319	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PNP—osteoporosis	4.98e-05	0.000319	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ACP5—osteoporosis	4.97e-05	0.000318	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—POMC—osteoporosis	4.96e-05	0.000317	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.91e-05	0.000314	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.79e-05	0.000306	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IRS1—osteoporosis	4.78e-05	0.000306	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ACP5—osteoporosis	4.71e-05	0.000302	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PKM—osteoporosis	4.68e-05	0.000299	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FDPS—osteoporosis	4.68e-05	0.000299	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—MTHFR—osteoporosis	4.64e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TPI1—osteoporosis	4.62e-05	0.000296	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—POMC—osteoporosis	4.61e-05	0.000295	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IRS1—osteoporosis	4.6e-05	0.000294	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6R—osteoporosis	4.49e-05	0.000288	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PGLS—osteoporosis	4.44e-05	0.000284	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPD2—osteoporosis	4.44e-05	0.000284	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IGF1—osteoporosis	4.43e-05	0.000284	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—osteoporosis	4.4e-05	0.000282	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TPI1—osteoporosis	4.38e-05	0.00028	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—P4HB—osteoporosis	4.35e-05	0.000278	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6R—osteoporosis	4.32e-05	0.000276	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—IDH2—osteoporosis	4.32e-05	0.000276	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GAPDH—osteoporosis	4.27e-05	0.000273	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA2—osteoporosis	4.24e-05	0.000271	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—OXCT1—osteoporosis	4.24e-05	0.000271	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ADCY5—osteoporosis	4.21e-05	0.00027	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—RAP1A—osteoporosis	4.15e-05	0.000266	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MGLL—osteoporosis	4.13e-05	0.000264	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—P4HB—osteoporosis	4.12e-05	0.000264	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SPP1—osteoporosis	4.08e-05	0.000261	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP27A1—osteoporosis	4.06e-05	0.00026	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ATIC—osteoporosis	4.06e-05	0.00026	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PNP—osteoporosis	4.06e-05	0.00026	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GAPDH—osteoporosis	4.04e-05	0.000259	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.98e-05	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.97e-05	0.000254	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ACP5—osteoporosis	3.95e-05	0.000253	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.9e-05	0.000249	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.89e-05	0.000249	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NFATC1—osteoporosis	3.84e-05	0.000246	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—DKK1—osteoporosis	3.81e-05	0.000244	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—osteoporosis	3.8e-05	0.000243	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—osteoporosis	3.79e-05	0.000243	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.71e-05	0.000237	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—POMC—osteoporosis	3.71e-05	0.000237	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IRS2—osteoporosis	3.69e-05	0.000236	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—WNT1—osteoporosis	3.67e-05	0.000235	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TPI1—osteoporosis	3.67e-05	0.000235	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.62e-05	0.000232	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LEP—osteoporosis	3.61e-05	0.000231	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGA—osteoporosis	3.57e-05	0.000229	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—IDH2—osteoporosis	3.51e-05	0.000225	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—P4HB—osteoporosis	3.45e-05	0.000221	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA2—osteoporosis	3.45e-05	0.000221	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—OXCT1—osteoporosis	3.45e-05	0.000221	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ESR1—osteoporosis	3.45e-05	0.00022	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GAPDH—osteoporosis	3.39e-05	0.000217	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MGLL—osteoporosis	3.36e-05	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ENO1—osteoporosis	3.36e-05	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PSMA2—osteoporosis	3.31e-05	0.000212	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PSMA5—osteoporosis	3.31e-05	0.000212	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.3e-05	0.000211	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—RAP1A—osteoporosis	3.3e-05	0.000211	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IRS1—osteoporosis	3.22e-05	0.000206	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ACP5—osteoporosis	3.21e-05	0.000206	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ENO1—osteoporosis	3.18e-05	0.000204	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.17e-05	0.000203	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.17e-05	0.000203	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSMA2—osteoporosis	3.14e-05	0.000201	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSMA5—osteoporosis	3.14e-05	0.000201	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—POMC—osteoporosis	3.1e-05	0.000198	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6R—osteoporosis	3.02e-05	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TPI1—osteoporosis	2.99e-05	0.000191	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1—osteoporosis	2.98e-05	0.000191	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CALCA—osteoporosis	2.92e-05	0.000187	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.88e-05	0.000184	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—osteoporosis	2.86e-05	0.000183	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—IDH2—osteoporosis	2.86e-05	0.000183	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—P4HB—osteoporosis	2.81e-05	0.00018	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GAPDH—osteoporosis	2.76e-05	0.000176	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.69e-05	0.000172	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP19A1—osteoporosis	2.69e-05	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—RAP1A—osteoporosis	2.68e-05	0.000172	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ENO1—osteoporosis	2.67e-05	0.000171	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—osteoporosis	2.66e-05	0.00017	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—osteoporosis	2.66e-05	0.00017	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KL—osteoporosis	2.65e-05	0.00017	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PSMA2—osteoporosis	2.63e-05	0.000168	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PSMA5—osteoporosis	2.63e-05	0.000168	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ACP5—osteoporosis	2.61e-05	0.000167	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.58e-05	0.000165	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—osteoporosis	2.56e-05	0.000164	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—osteoporosis	2.55e-05	0.000163	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TPI1—osteoporosis	2.43e-05	0.000155	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.34e-05	0.00015	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—P4HB—osteoporosis	2.28e-05	0.000146	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GAPDH—osteoporosis	2.24e-05	0.000143	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ADCY5—osteoporosis	2.19e-05	0.00014	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GPX1—osteoporosis	2.19e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—RAP1A—osteoporosis	2.18e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ENO1—osteoporosis	2.17e-05	0.000139	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PSMA5—osteoporosis	2.14e-05	0.000137	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PSMA2—osteoporosis	2.14e-05	0.000137	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP19A1—osteoporosis	2.13e-05	0.000136	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ADCY5—osteoporosis	2.08e-05	0.000133	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—osteoporosis	2.02e-05	0.000129	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—osteoporosis	2e-05	0.000128	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—osteoporosis	1.92e-05	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—osteoporosis	1.91e-05	0.000122	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.9e-05	0.000122	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS2—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—osteoporosis	1.79e-05	0.000115	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—osteoporosis	1.79e-05	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ENO1—osteoporosis	1.77e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ADCY5—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PSMA5—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PSMA2—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GPX1—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.73e-05	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—POMC—osteoporosis	1.61e-05	0.000103	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—osteoporosis	1.6e-05	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS1—osteoporosis	1.59e-05	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6R—osteoporosis	1.49e-05	9.55e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ADCY5—osteoporosis	1.42e-05	9.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPX1—osteoporosis	1.41e-05	9.04e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.41e-05	9.03e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—osteoporosis	1.35e-05	8.62e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—osteoporosis	1.3e-05	8.34e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—POMC—osteoporosis	1.28e-05	8.2e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ADCY5—osteoporosis	1.15e-05	7.38e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPX1—osteoporosis	1.15e-05	7.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—osteoporosis	1.06e-05	6.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—POMC—osteoporosis	1.04e-05	6.67e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—osteoporosis	8.84e-06	5.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—osteoporosis	8.82e-06	5.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—POMC—osteoporosis	8.48e-06	5.43e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—osteoporosis	6.65e-06	4.25e-05	CbGpPWpGaD
